We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Image: Chest x-rays used in the COVID-Net study show differing infection extent and opacity in the lungs of COVID-19 patients (Photo courtesy of University of Waterloo)

New Tool Uses Deep-Learning AI Technology to Accurately Assess Severity of Lung Infections in COVID-19 Patients

A new artificial intelligence (AI) technology is capable of assessing the severity of COVID-19 cases with a promising degree of accuracy. More...
04 Jun 2021
Image: Column 1 and 2 show lung ultrasounds without and with annotated COVID-19 biomarkers (orange: moderate, red: severe). Columns 3 and 4 respectively show the semantic segmentations and contours of COVID-19 markers by means of deep learning analysis (Photo courtesy of Eindhoven University of Technology)

Intelligent Lung Ultrasound Provides Crucial Support for COVID-19 Testing Within Minutes

Using fairly simple ultrasound machines that are enhanced with artificial intelligence (AI) could make it possible to establish whether a patient is suffering from severe lung disease, possibly COVID-19, within a few minutes. More...
03 Jun 2021
Illustration

Cutting-Edge MRI Method Reveals Persistent COVID-19 Lung Damage Overlooked by Routine CT

A study using a cutting-edge method of imaging has identified persistent damage to the lungs of COVID-19 patients at least three months after they were discharged from hospital, and for some patients even longer. This damage was not detected by routine CT scans and clinical tests, and the patients would consequently normally be told their lungs are normal. More...
31 May 2021
Image: As seen here with microscopy, lung epithelial cells infected with SARS-CoV-2 (left, yellow) were successfully treated with the STING agonist diABZI (right) by Penn Medicine researchers (Photo courtesy of Penn Medicine)

New Drug That Blocks Multiple SARS-CoV-2 Variants Could Be a Game-Changer in Treating COVID-19 Infection

Scientists have discovered a new drug that blocks multiple SARS-CoV-2 variants in mice and could prove to be a potential game-changer in the treatment of COVID-19. More...
31 May 2021
Illustration

Machine Learning Model Predicts Treatment with Dialysis or Death for Hospitalized COVID-19 Patients

A team of researchers have created a machine learning model to predict treatment with dialysis or death for hospitalized COVID-19 patients. More...
31 May 2021
Illustration

GlaxoSmithKline and Vir Biotechnology’s COVID-19 Antibody Drug Granted FDA Emergency Use Authorization

GlaxoSmithKline plc (London, UK) and Vir Biotechnology, Inc. (San Francisco, CA, USA) have been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for sotrovimab (previously VIR-7831) for the treatment of mild-to-moderate COVID-19 in high-risk adults and pediatric patients. More...
28 May 2021
Image: A new study published in Science Advances found that inhalable nanobodies targeting the spike protein of the SARS-CoV-2 coronavirus can prevent and treat severe COVID-19 in hamsters. Here, bronchioles of hamsters sick with COVID-19 untreated (left) and treated with inhalable nanobodies (right) show the impact of the approach (Photo courtesy of Nambulli et al., Science Advances)

Inhalable Nanobody-Based Treatment Administered at Ultra-Low Doses Could Prevent and Treat SARS-CoV-2 Infections

A new study has found that inhalable nanobodies targeting the spike protein of the SARS-CoV-2 coronavirus can prevent and treat severe COVID-19 in hamsters. More...
27 May 2021
Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Diagnosis Display System
C1216W
New
Blanket Warming Cabinet
EC250
Copyright © 2000-2024 Globetech Media. All rights reserved.